Loading...
Duvelisib: A Phosphoinositide-3 Kinase δ/γ Inhibitor for Chronic Lymphocytic Leukemia
INTRODUCTION: Frontline chemotherapy is successful against chronic lymphocytic leukemia (CLL), but results in untoward toxicity. Further, prognostic factors, cytogenetic anomalies, and compensatory cellular signaling lead to therapy resistance or disease relapse. Therefore, for the past few years, d...
Saved in:
| Published in: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5584596/ https://ncbi.nlm.nih.gov/pubmed/28388280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2017.1312338 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|